The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19
Bakiye Göker Bağca, Çığır Biray Avcı
Topics & Concepts
RuxolitinibJAK-STAT signaling pathwaystatJanus kinaseSignal transductionJanus kinase 1Coronavirus disease 2019 (COVID-19)MedicineCancer researchSTAT3ImmunologyBiologyMyelofibrosisInternal medicineCell biologyTyrosine kinaseBone marrowDiseaseInfectious disease (medical specialty)Autoimmune and Inflammatory Disorders ResearchCytokine Signaling Pathways and InteractionsMyeloproliferative Neoplasms: Diagnosis and Treatment